Scribble

Price Momentum

EDVA is trading near the bottom of its 52-week range and below its 200-day simple moving average.
Price change

The price of EDVA shares has decreased $0.00 since the market last closed. This is a 2.44% drop.
Closed at $0.16.

The stock has since dropped $0.00 in after-hours trading.

Key terms

Endovia Health Sciences, Inc. engages in the sale and production of natural and healthy drinks. It offers products under the brands of Salt Tequila and Chispo Tequila. The company was founded on September 3, 1992 and is headquartered in Fort Lauderdale, FL.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Market cap: $1.73M

A market capitalization up to $300 million places EDVA in the micro-capitalization category.

Key terms

Smart score

Oct 06, 2026 4:29pm ET Endovia Health Raises Capital Through Recent Equity Issuance by TipRanks Oct 05, 2026 4:32pm ET Endovia Gains MUMS Status for CannEpil Canine Therapy by TipRanks Oct 05, 2026 9:15am ET Endovia Health Sciences announces FDA minor-use determination for CannEpil by TipRanks Sep 24, 2026 4:53pm ET Endovia Secures New Funding to Advance CannEpil Program by TipRanks Sep 22, 2026 4:28pm ET Endovia secures $500,000 convertible financing for CannEpil by TipRanks Aug 31, 2026 4:29pm ET Endovia advances CannEpil amid supportive federal rescheduling move by TipRanks Aug 28, 2026 5:22pm ET Endovia Health Sciences Raises Capital Through Equity Offering by TipRanks Aug 26, 2026 5:02pm ET Endovia appoints interim leaders with incentive-focused pay by TipRanks Aug 25, 2026 8:58am ET Endovia launches FDA-backed CannEpil veterinary pain program by TipRanks

Oct 05, 2026 8:45am ET Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway by GlobeNewswire Sep 22, 2026 9:30am ET Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways by GlobeNewswire Aug 31, 2026 8:30am ET Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline by GlobeNewswire Aug 25, 2026 8:30am ET Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program by GlobeNewswire

1-year income & revenue

Total revenue: $73.07K (1Y), $0.00 (Q2)

Total Revenue decreased 98.24% since last year and decreased 100.0% since last quarter.
Net income: -$25.23M (1Y), -$2.01M (Q2)

Net Income decreased 6.22% since last year and increased 5.99% since last quarter.
Earnings per share: -$47.86 (1Y), -$0.67 (Q2)

EPS increased 32.58% since last year and increased 69.53% since last quarter.

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

How competitors are chosen

EDVA's competitors are included in the Health Services sector and Medical/Nursing Services group
Market cap: $1.73M

A market capitalization up to $300 million places EDVA in the micro-capitalization category.